New Key Statistics Module, Z-Score and F-Score
AMEX:MTNB Key Ratios
Market Cap $ M | 18.41 |
Enterprise Value $ M | 6.66 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 0.93 |
Price/Sales | 14.03 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 1.00 |
EPS (TTM) $ | -5.50 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | 6.30 |
5-y EBITDA Growth Rate % | 5.90 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -0.28 |
EV-to-EBITDA | -0.29 |
PEG | -- |
Shares Outstanding M | 5.02 |
Net Margin (%) | -- |
Operating Margin % | -- |
Pre-tax Margin (%) | -- |
Quick Ratio | 6.39 |
Current Ratio | 6.39 |
ROA % (ttm) | -86.20 |
ROE % (ttm) | -110.25 |
ROIC % (ttm) | -231.69 |
Dividend Yield % | -- |
Altman Z-Score | -- |
MTNB Number of Guru Trades
MTNB Volume of Guru Trades
Gurus Latest Trades with AMEX:MTNB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
AMEX:MTNB is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Matinas BioPharma Holdings Inc Insider Transactions
No Available Data
News about AMEX:MTNB
Total 0- 1